Publications

Samanta, J, and RA Hauser. 2007. “Duodenal Levodopa Infusion for the Treatment of Parkinson’s Disease.”. Expert Opinion Pharmacother.

Hauser, RA, L Salin, N Juhel, and VL Konyago. 2007. “Randomized Trial of the Triple Monoamine Reuptake Inhibitor NS 2330 (tesofensine) in Early Parkinson’s Disease.”. Movement Disorders.

Zesiewicz, TA, and RA Hauser. 2007. “Medical Treatment of Motor and Nonmotor Features of Parkinson’s Disease.”. Continuum.

Taylor, JP, MM Hulihan, JM Kachergus, HL Melrose, SJ Lincoln, KM Hinkle, JT Stone, et al. 2007. “Leucine-Rich Repeat Kinase 1:  a Paralog of LRRK2 and a Candidate Gene for Parkinson’s Disease.”. Neurogenetics.

Zesiewicz, TA, CL Ward, RA Hauser, J Sanchez-Ramos, JF Staffetti, and K Sullivan. 2007. “A Double-Blind Placebo-Controlled Trial of Zonisamide (Zonegran) in the Treatment of Essential Tremor.”. Movement Disorders.

Investigators, The NINDS NET-PD, and RA Hauser. 2007. “A Randomized Clinical Trial of Coenzyme Q10 and GPI-1485 in Early Parkinson’s Disease.”. Neurology.

Zesiewicz, TA, CL Ward, RA Hauser, JA Pease Campbell, and KL Sullivan. 2007. “Pregabalin (Lyrica) in the Treatment of Essential Tremor.”. Movement Disorders.

Sullivan, KL, CL Ward, RA Hauser, and TA Zesiewicz. 2007. “Prevalence and Treatment of Non-Motor Symptoms in Parkinson’s Disease”. Parkinsonism Relat Disord.

Wolfrath, SC, AR Borenstein, S Schwartz, RA Hauser, KL Sullivan, and TA Zesiewicz. 2006. “Use of Nutritional Supplements in Parkinson’s Disease Patients.”. Movement Disorders.

Ziesiewicz, TA, A Tullidge, J Tidwell, KL Sullivan, and RA Hauser. 2006. “Topiramate-Induced Psychosis in Patients With Essential Tremor: Report of 2 Cases.”. Clinical Neuropharmacology.